Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB)

MLA

Alan Yao, et al. “Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB).” Gastroenterology, vol. 140, May 2011, p. S-896. EBSCOhost, https://doi.org/10.1016/s0016-5085(11)63722-0.

APA

Alan Yao, Lillian Lou, Huy N. Trinh, Betty Chiang, Ho Bae, Patrick Marcellin, Calvin Q. Pan, E. Jenny Heathcote, & Sing Chan. (2011). Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB). Gastroenterology, 140, S-896. https://doi.org/10.1016/s0016-5085(11)63722-0

Chicago

Alan Yao, Lillian Lou, Huy N. Trinh, Betty Chiang, Ho Bae, Patrick Marcellin, Calvin Q. Pan, E. Jenny Heathcote, and Sing Chan. 2011. “Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB).” Gastroenterology 140 (May): S-896. doi:10.1016/s0016-5085(11)63722-0.